arrow
M

Markus Peck-Radosavljevic

Klinikum Klagenfurt am Wörthersee
H指数:84
被引数:2.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Severe alpha-1 antitrypsin deficiency is associated with a higher risk of complications after first decompensation than other aetiologies of cirrhosis

严重α-1抗胰蛋白酶缺乏症与首次失代偿后并发症风险高于其他肝硬化病因相关。

2025-06-010
OAAI
Regional Differences in Clinical Presentation and Prognosis of Patients With Post-Sustained Virologic Response Hepatocellular Carcinoma
2024-01-012
OA
Securing wider EU commitment to the elimination of hepatitis C virus
2022-12-1410
OAAI
Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study

肝癌患者合并SARS-CoV-2感染的结局: 一项国际性、多中心、队列研究

2022-06-2310
OAAI
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

丙型肝炎病毒患病率的全球变化以及护理2015年和2020的级联: 一项建模研究

2022-05-01368
OAAI
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score
2022-02-01166
OA
Hepatitis D virus (HDV) prevalence in Austria is low but causes considerable morbidity due to fast progression to cirrhosis

奥地利的丁型肝炎病毒 (HDV) 患病率较低,但由于快速进展为肝硬化而导致相当高的发病率

2021-12-0724
OAAI
The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomes
2021-05-2118
OAAI
NASH limits anti-tumour surveillance in immunotherapy-treated HCC

NASH限制了免疫治疗HCC的抗肿瘤监测

Nature
IF48.5
2021-03-240
OAAI